AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review

November 2021 | 50 pages | ID: A9159FCFF4AEN
GlobalData

Abstracts

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo in Europe), is a single sufentanil sublingual tablet for treating of moderate-to-severe acute pain. Its pipeline also includes Zalviso (for US market), a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. The company commercializes its EC approved Zalviso under license agreement with Grunenthal in Europe and Australia. AcelRx is headquartered in Hayward, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

Aug 16,2021: AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
May 17,2021: AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
Mar 31,2021: AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
Mar 22,2021: AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference
Mar 15,2021: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AcelRx Pharmaceuticals Inc - Key Facts
AcelRx Pharmaceuticals Inc - Key Employees
AcelRx Pharmaceuticals Inc - Key Employee Biographies
AcelRx Pharmaceuticals Inc - Major Products and Services
AcelRx Pharmaceuticals Inc - History
AcelRx Pharmaceuticals Inc - Company Statement
AcelRx Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AcelRx Pharmaceuticals Inc - Business Description
Other Break-up: Contract and Other Collaboration
Overview
Performance
Other Break-up: Product Sales
Overview
Performance
AcelRx Pharmaceuticals Inc - Corporate Strategy
AcelRx Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
AcelRx Pharmaceuticals Inc - Strengths
AcelRx Pharmaceuticals Inc - Weaknesses
AcelRx Pharmaceuticals Inc - Opportunities
AcelRx Pharmaceuticals Inc - Threats
AcelRx Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AcelRx Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 16, 2021: AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
May 17, 2021: AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
Mar 31, 2021: AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
Mar 22, 2021: AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference
Mar 15, 2021: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 08, 2021: AcelRx to Host Fourth Quarter and Full Year 2020 Financial Results Call and Webcast on March 15, 2021
Nov 05, 2020: AcelRx Pharmaceuticals reports third quarter 2020 financial results
Aug 10, 2020: AcelRx Pharmaceuticals reports second quarter 2020 financial results
May 11, 2020: AcelRx Pharmaceuticals reports first quarter 2020 financial results
May 04, 2020: AcelRx to Host First Quarter 2020 Financial Results Call and Webcast on Monday, May 11th, 2020

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AcelRx Pharmaceuticals Inc, Key Facts
AcelRx Pharmaceuticals Inc, Key Employees
AcelRx Pharmaceuticals Inc, Key Employee Biographies
AcelRx Pharmaceuticals Inc, Major Products and Services
AcelRx Pharmaceuticals Inc, History
AcelRx Pharmaceuticals Inc, Subsidiaries
AcelRx Pharmaceuticals Inc, Key Competitors
AcelRx Pharmaceuticals Inc, Ratios based on current share price
AcelRx Pharmaceuticals Inc, Annual Ratios
AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1)
AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...2)
AcelRx Pharmaceuticals Inc, Interim Ratios
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AcelRx Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AcelRx Pharmaceuticals Inc, Performance Chart (2016 - 2020)
AcelRx Pharmaceuticals Inc, Ratio Charts
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021